Searched for
STERISCIENCE
JM Financial initiates coverage on OneSource Specialty Pharma with a Buy call, target price Rs 2,049JM Financial initiates a Buy call on OneSource Specialty Pharma, setting a target price of Rs 2,049, driven by its unique CDMO positioning ...- 360 ONE Asset acquires stake in OneSource Specialty Pharma360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undi...
- Strides Pharma's OneSource raises Rs 801 crore in pre-listing roundOneSource Specialty Pharma, an associate of Strides Pharma, secured Rs. 801 crore from investors including HBM Healthcare Investments and W...
- OneSource in talks to raise Rs 1,670 crore in pre-listing roundOneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopha...
- Strides secures shareholders' nod for OneSource specialty CDMO unitStrides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The comp...
- Proxy advisors vote against Strides Pharma’s consolidation schemeProxy advisory firms have recommended investors vote against Strides Pharma's proposal to consolidate businesses with Steriscience and Ones...
- Strides Pharma to spin off CDMO assets to form a separate unitPharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...
- Strides to invest Rs 135 crore to pick about 54% stake in SteriScience PharmaThe business will require a total investment of Rs 400 crore (Rs 250 crore equity and Rs 1,50 crore debt) until it achieves an operational ...
Load More